Concepedia

Rukiye-Nazan Eraslan

RE

Statistics

Publications

2

Citations

23

H-Index

2

Active since

2022

Affiliations

Astellas Pharma (United States)(Current)

Rukiye-Nazan Eraslan is an author at Astellas Pharma (United States) specializing in oncology, cancer immunology, and tumor microenvironment.

Publications per year

2022–2023

2

Publications

2

ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts

Laxminarasimha Donthireddy, Prashanthi Vonteddu, Tushar Murthy et al. · Journal of Cancer · 2022 · 12 citations · Full text

, , +17

SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy

John K. Cini, Susan Dexter, D. J. Rezac et al. · Frontiers in Immunology · 2023 · 11 citations · Full text

, , +17

1–2 of 2